Sanofi Stock Quote 1SAN - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

91.79

Bid

92.08

Ask

92.15

Volume

2,505

90.96 Day's Range 91.79

84.98 52 Week Range 107.96

Market Cap

114.98B

Previous Close

90.25

Open

91.19

Last Trade

100

91.79

Last Trade Time

06:18:10

Financial Volume

VWAP

Average Volume (3m)

746

Shares Outstanding

1,252,640,466

Dividend Yield

4.10%

PE Ratio

21.30

Earnings Per Share (EPS)

4.31

Revenue

43.07B

Net Profit

5.4B

Sector

Health & Allied Services,nec

Industry

Pharmaceutical Preparations

Website

www.sanofi.com

Headquarters

Paris, Paris, Fra

Founded

1994

Sanofi is listed in the Health & Allied Services sector of the Italian Stock Exchange with ticker 1SAN. The last closing price for Sanofi was 90.25 €. Over the last year, Sanofi shares have traded in a share price range of 84.98 € to 107.96 €.

Sanofi currently has 1,252,640,466 shares outstanding. The market capitalization of Sanofi is 113.05 € billion. Sanofi has a price to earnings ratio (PE ratio) of 21.30.

Communiqué de presse : Sanofi lance un programme de phase III pour son vaccin VPC21 et élargit sa collaboration avec SK Bioscience afin de développer une nouvelle génération de vaccins pneumococciques conjugués

Communiqué de presse : Sanofi lance un programme de phase III pour son vaccin VPC21 et élargit sa collaboration avec SK Bioscience afin de développer une nouvelle génération de vaccins...

Press Release: Sanofi initiates phase 3 program for PCV21 and expands collaboration with SK bioscience for next-generation pneumococcal conjugate vaccines

Press Release: Sanofi initiates phase 3 program for PCV21 and expands collaboration with SK bioscience for next-generation pneumococcal conjugate vaccines Sanofi initiates phase 3 program for...

Communiqué de presse - Jean-Paul Kress rejoint le Conseil d’administration de Sanofi

Communiqué de presse - Jean-Paul Kress rejoint le Conseil d’administration de Sanofi Jean-Paul Kress rejoint le Conseil d’administration de Sanofi Paris, le 19 décembre 2024. Le Conseil...

Presse release: Jean-Paul Kress to join Sanofi's Board of Directors

Presse release: Jean-Paul Kress to join Sanofi's Board of Directors Jean-Paul Kress to join Sanofi's Board of Directors Paris, December 19, 2024. Sanofi's Board of Directors is pleased to...

Press Release: Duvakitug positive phase 2b results demonstrate best-in-class potential in ulcerative colitis and Crohn’s disease

Press Release: Duvakitug positive phase 2b results demonstrate best-in-class potential in ulcerative colitis and Crohn’s disease Duvakitug positive phase 2b results demonstrate best-in-class...

Communiqué de presse : Les résultats positifs de phase IIb concernant le duvakitug illustrent son potentiel de meilleur médicament de sa catégorie pour le traitement de la colite ulcéreuse et de la maladie de Crohn

Communiqué de presse : Les résultats positifs de phase IIb concernant le duvakitug illustrent son potentiel de meilleur médicament de sa catégorie pour le traitement de la colite ulcéreuse et de...

Press Release: Availability of the Q4 2024 Aide-mémoire

Press Release: Availability of the Q4 2024 Aide-mémoire Availability of the Q4 2024 Aide-mémoire Paris, France – December 17, 2024. Sanofi announced today that its Q4 2024 Aide-mémoire is...

Communiqué de presse : Mise en ligne du document « Q4 2024 Aide-mémoire »

Communiqué de presse : Mise en ligne du document « Q4 2024 Aide-mémoire » Mise en ligne du document « Q4 2024 Aide-mémoire » Paris, France, le 17 Décembre 2024. Sanofi annonce la mise en ligne...

Communiqué de presse : Le tolebrutinib obtient la désignation de « Médicament innovant » de la FDA pour le traitement de la sclérose en plaques secondairement progressive sans poussées

Communiqué de presse : Le tolebrutinib obtient la désignation de « Médicament innovant » de la FDA pour le traitement de la sclérose en plaques secondairement progressive sans poussées Le...

Press Release: Tolebrutinib designated Breakthrough Therapy by the FDA for non-relapsing secondary progressive multiple sclerosis

Press Release: Tolebrutinib designated Breakthrough Therapy by the FDA for non-relapsing secondary progressive multiple sclerosis Tolebrutinib designated Breakthrough Therapy by the FDA for...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	2.69	3.01907968575	89.1	92	87.48	1054	91.06776176	DE
4	-4.49	-4.66348151226	96.28	96.28	87.48	873	91.2681651	DE
12	-12.01	-11.570327553	103.8	104.22	87.48	746	94.52910985	DE
26	3.78	4.29496648108	88.01	107.96	87.48	884	96.07690652	DE
52	3.19	3.60045146727	88.6	107.96	84.98	844	93.15615243	DE
156	4.44	5.08299942759	87.35	107.96	76.36	974	91.65982021	DE
260	0.78	0.85704867597	91.01	107.96	68	1482	87.78501268	DE

1SAN - Frequently Asked Questions (FAQ)

What is the current Sanofi share price?

The current share price of Sanofi is 91.79 €

How many Sanofi shares are in issue?

Sanofi has 1,252,640,466 shares in issue

What is the market cap of Sanofi?

The market capitalisation of Sanofi is EUR 113.05B

What is the 1 year trading range for Sanofi share price?

Sanofi has traded in the range of 84.98 € to 107.96 € during the past year

What is the PE ratio of Sanofi?

The price to earnings ratio of Sanofi is 21.3

What is the cash to sales ratio of Sanofi?

The cash to sales ratio of Sanofi is 2.67

What is the reporting currency for Sanofi?

Sanofi reports financial results in EUR

What is the latest annual turnover for Sanofi?

The latest annual turnover of Sanofi is EUR 43.07B

What is the latest annual profit for Sanofi?

The latest annual profit of Sanofi is EUR 5.4B

What is the registered address of Sanofi?

The registered address for Sanofi is 46, AVENUE DE LA GRANDE ARMEE, PARIS, PARIS, 75017

What is the Sanofi website address?

The website address for Sanofi is www.sanofi.com

Which industry sector does Sanofi operate in?

Sanofi operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
WFTC26Finanzatech Spa	0.035 € (40.00%)	30.1k
WSBCBSicily by Car SpA	0.0194 € (29.33%)	9.3k
ATONAton Green Storage Spa	2.44 € (8.93%)	27k
MNLMonnalisa SPA	1.20 € (7.14%)	50.59k
1SPCEVirgin Galactic Holdings Inc	6.70 € (7.03%)	200
WNUS26Nusco Spa	0.0901 € (-25.54%)	998
1DUEDuerr AG	20.66 € (-14.70%)	50
BSTBanca Sistema SpA	1.232 € (-12.75%)	885.54k
1ECLEcolab Inc	227.00 € (-10.98%)	20
U24Ucapital24 Spa	0.546 € (-10.20%)	46.8k
TITTelecom Italia SpA	0.2422 € (0.17%)	111.27M
ISPIntesa Sanpaolo Spa	3.8245 € (-0.25%)	13.77M
SPMSaipem Spa	2.485 € (0.12%)	10.12M
TITRTelecom Italia	0.282 € (0.18%)	9.25M
ENELEnel Spa	6.826 € (0.29%)	5.8M